Yan M - Search Results

1

Alteration of tumor spectrum by ISGylation in p53-deficient mice.

Yin X, Cong X, Yan M, Zhang DE. Yin X, et al. Among authors: yan m. Cancer Biol Ther. 2009 Jun;8(12):1167-72. doi: 10.4161/cbt.8.12.8558. Cancer Biol Ther. 2009. PMID: 19652527 Free article. No abstract available.

2

Protein ISGylation modulates the JAK-STAT signaling pathway.

Malakhova OA, Yan M, Malakhov MP, Yuan Y, Ritchie KJ, Kim KI, Peterson LF, Shuai K, Zhang DE. Malakhova OA, et al. Among authors: yan m. Genes Dev. 2003 Feb 15;17(4):455-60. doi: 10.1101/gad.1056303. Genes Dev. 2003. PMID: 12600939 Free PMC article.

3

Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection.

Ritchie KJ, Hahn CS, Kim KI, Yan M, Rosario D, Li L, de la Torre JC, Zhang DE. Ritchie KJ, et al. Among authors: yan m. Nat Med. 2004 Dec;10(12):1374-8. doi: 10.1038/nm1133. Epub 2004 Nov 7. Nat Med. 2004. PMID: 15531891

4

Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.

Yan M, Burel SA, Peterson LF, Kanbe E, Iwasaki H, Boyapati A, Hines R, Akashi K, Zhang DE. Yan M, et al. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17186-91. doi: 10.1073/pnas.0406702101. Epub 2004 Nov 29. Proc Natl Acad Sci U S A. 2004. PMID: 15569932 Free PMC article.

5

Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling.

Kim KI, Malakhova OA, Hoebe K, Yan M, Beutler B, Zhang DE. Kim KI, et al. Among authors: yan m. J Immunol. 2005 Jul 15;175(2):847-54. doi: 10.4049/jimmunol.175.2.847. J Immunol. 2005. PMID: 16002682

6

Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.

Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. Kim KI, et al. Among authors: yan m. Mol Cell Biol. 2006 Jan;26(2):472-9. doi: 10.1128/MCB.26.2.472-479.2006. Mol Cell Biol. 2006. PMID: 16382139 Free PMC article.

7

A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.

Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, Chen IM, Chen Z, Rowley JD, Willman CL, Zhang DE. Yan M, et al. Nat Med. 2006 Aug;12(8):945-9. doi: 10.1038/nm1443. Epub 2006 Jul 30. Nat Med. 2006. PMID: 16892037

8

A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy.

Boyapati A, Yan M, Peterson LF, Biggs JR, Le Beau MM, Zhang DE. Boyapati A, et al. Among authors: yan m. Blood. 2007 May 1;109(9):3963-71. doi: 10.1182/blood-2006-09-045583. Epub 2006 Dec 29. Blood. 2007. PMID: 17197431 Free PMC article.

9

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.

Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J, Zhang FX, Weng XQ, Shen ZX, Chen J, Gu LJ, Yan M, Zhang DE, Chen SJ, Wang ZY, Chen Z. Zhou GB, et al. Among authors: yan m. Blood. 2007 Apr 15;109(8):3441-50. doi: 10.1182/blood-2006-06-032250. Epub 2006 Dec 29. Blood. 2007. PMID: 17197433 Free PMC article.

10

The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

Peterson LF, Yan M, Zhang DE. Peterson LF, et al. Among authors: yan m. Blood. 2007 May 15;109(10):4392-8. doi: 10.1182/blood-2006-03-012575. Epub 2007 Feb 6. Blood. 2007. PMID: 17284535 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,186 results

Search Page

Filters